{"id":44279,"date":"2022-05-24T15:01:09","date_gmt":"2022-05-24T13:01:09","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\/"},"modified":"2022-05-24T15:01:09","modified_gmt":"2022-05-24T13:01:09","slug":"rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\/","title":{"rendered":"RapidAI Receives FDA 510(k) Clearance for Pulmonary Embolism Triage & Notification"},"content":{"rendered":"
\n

\nClinically driven AI platform extends physicians\u2019 ability to prioritize patients, reduce time to treatment and improve patient outcomes<\/i>\n<\/p>\n

SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI<\/a>, the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, announced today that it has received FDA 510(k) clearance for its Rapid PE Triage & Notification<\/a> product for fast identification and communication of suspected central pulmonary embolism \u2014 further strengthening RapidAI\u2019s industry-leading clinical AI platform.\n<\/p>\n

<\/a><\/p>\n

\nNew research shows that death rates for pulmonary embolism have been on the rise over the last decade<\/a>, with the biggest increase among people under 65. For those who experience and survive a PE incident, one-third will have a recurrence within 10 years<\/a>. Increasing access to clinically validated technology will be key to helping hospitals more efficiently coordinate care, make accurate diagnoses in a timely manner, and get PE patients to treatment faster, leading to better outcomes.\n<\/p>\n

\n\u201cBuilding on our expertise in stroke, we\u2019re confident this technology will help modernize PE care and meaningfully improve patient outcomes,\u201d said Karim Karti, CEO of RapidAI. \u201cOur goal is to build solutions that address the specific challenges associated with treating various conditions, as well as the communication and workflow issues faced by hospitals globally. From stroke to aneurysm to PE, we\u2019re proud of how much RapidAI has grown and are excited to continue to redefine the patient care journey.\u201d\n<\/p>\n

\nRapid PE Triage & Notification, in conjunction with Rapid Workflow for PE<\/a>, will enable care teams to more easily manage the entire patient care journey, from the moment a suspected PE patient is identified to diagnosis and through treatment. By automatically identifying a suspected pulmonary embolism and delivering real-time notifications to physicians, patients can be triaged faster and care teams aligned more quickly, reducing overall time to treatment.\n<\/p>\n

\n\u201cI\u2019m excited to see first-hand how artificial intelligence will transform the way we triage and manage PE, a historically complicated process involving a diverse care team,\u201d said Dr. Jimmy Kerrigan, an Interventional Cardiologist at Ascension St. Thomas Heart. \u201cAfter seeing what RapidAI technology has done for stroke, I\u2019m optimistic about its potential to optimize our care for patients and to hopefully improve patient outcomes.\u201d\n<\/p>\n

\nJoin us at SIR\u2019s 2022 Annual Scientific Meeting<\/a>, Booth #346, to learn more about RapidAI clinically-validated solutions, and see a product demonstration of Rapid PE.<\/i>\n<\/p>\n

\nAbout RapidAI<\/b>\n<\/p>\n

\nRapidAI<\/a> is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. Empowering physicians to make faster decisions for better patient outcomes, RapidAI is leading the next evolution of clinical decision-making and patient workflow. Based on intelligence gained from over 5 million scans in more than 2,000 hospitals in over 60 countries, the Rapid\u00ae platform transforms care coordination, offering care teams a level of patient visibility never before possible. RapidAI \u2013 where AI meets patient care.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nErin Dixon
\n
Merritt Group, Inc.
\n
774.573.3941
\n
rapidai@merrittgrp.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Clinically driven AI platform extends physicians\u2019 ability to prioritize patients, reduce time to treatment and improve patient outcomes SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, announced today that it has received FDA 510(k) clearance for its Rapid PE Triage & Notification product for fast … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44279","6":"format-standard","7":"category-industry"},"yoast_head":"\nRapidAI Receives FDA 510(k) Clearance for Pulmonary Embolism Triage & Notification - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RapidAI Receives FDA 510(k) Clearance for Pulmonary Embolism Triage & Notification - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Clinically driven AI platform extends physicians\u2019 ability to prioritize patients, reduce time to treatment and improve patient outcomes SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, announced today that it has received FDA 510(k) clearance for its Rapid PE Triage & Notification product for fast ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-24T13:01:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220524005075\/en\/1462998\/21\/rapid-AI-logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"RapidAI Receives FDA 510(k) Clearance for Pulmonary Embolism Triage & Notification\",\"datePublished\":\"2022-05-24T13:01:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\\\/\"},\"wordCount\":485,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220524005075\\\/en\\\/1462998\\\/21\\\/rapid-AI-logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\\\/\",\"name\":\"RapidAI Receives FDA 510(k) Clearance for Pulmonary Embolism Triage & Notification - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220524005075\\\/en\\\/1462998\\\/21\\\/rapid-AI-logo.jpg\",\"datePublished\":\"2022-05-24T13:01:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220524005075\\\/en\\\/1462998\\\/21\\\/rapid-AI-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220524005075\\\/en\\\/1462998\\\/21\\\/rapid-AI-logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RapidAI Receives FDA 510(k) Clearance for Pulmonary Embolism Triage & Notification\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RapidAI Receives FDA 510(k) Clearance for Pulmonary Embolism Triage & Notification - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\/","og_locale":"en_US","og_type":"article","og_title":"RapidAI Receives FDA 510(k) Clearance for Pulmonary Embolism Triage & Notification - Pharma Trend","og_description":"Clinically driven AI platform extends physicians\u2019 ability to prioritize patients, reduce time to treatment and improve patient outcomes SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, announced today that it has received FDA 510(k) clearance for its Rapid PE Triage & Notification product for fast ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-24T13:01:09+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220524005075\/en\/1462998\/21\/rapid-AI-logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"RapidAI Receives FDA 510(k) Clearance for Pulmonary Embolism Triage & Notification","datePublished":"2022-05-24T13:01:09+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\/"},"wordCount":485,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220524005075\/en\/1462998\/21\/rapid-AI-logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\/","url":"https:\/\/pharma-trend.com\/en\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\/","name":"RapidAI Receives FDA 510(k) Clearance for Pulmonary Embolism Triage & Notification - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220524005075\/en\/1462998\/21\/rapid-AI-logo.jpg","datePublished":"2022-05-24T13:01:09+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220524005075\/en\/1462998\/21\/rapid-AI-logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220524005075\/en\/1462998\/21\/rapid-AI-logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-fda-510k-clearance-for-pulmonary-embolism-triage-notification\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"RapidAI Receives FDA 510(k) Clearance for Pulmonary Embolism Triage & Notification"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44279"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44279\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44279"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44279"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}